About Meditrial Editorial Team

This author has not yet filled in any details.
So far Meditrial Editorial Team has created 146 blog entries.

Sviluppo clinico di farmaci e dispositivi medici: una panoramica degli aspetti più innovativi e di maggiore interesse

2022-07-05T08:53:13+00:00May 4th, 2022|Categories: AboutPharma|

Nasce su AboutPharma Online, in Collaborazione con Meditrial, uno spazio per illustrare le nuove roadmap per lo sviluppo clinico e come prepararsi. Lo sviluppo clinico è un termine tradizionalmente utilizzato per definire l'intero processo di immissione sul [...]

MDCG 2022-2 Guidance on general principles of clinical evidence for in Vitro Diagnostic medical devices (IVDs)

2023-03-29T14:46:55+00:00January 28th, 2022|Categories: Uncategorized|Tags: , , , , , |

New #MDCG Guidance on general principles for #clinicalevidence and the continuous process of performance evaluation for #IVDs has been published The guidance describes the approach by which collection, generation and documentation of supporting data for an IVD may be conducted prior to the placing [...]

MDCG 2022-1 Notice to third country manufacturers of SARS-CoV-2 in vitro diagnostic medical devices

2023-03-29T14:47:07+00:00January 12th, 2022|Categories: Compliance, Covid-19, Europe, Regulatory|Tags: , , , |

The MDCG 2022-1 Notice has been published It is addressed to manufacturers of SARS-CoV-2 IVDs based in a third country and who place or intend to place their in vitro diagnostics on the EU market. It highlights a number of common issues [...]

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

2023-03-29T14:47:59+00:00January 3rd, 2022|Categories: Clinical Trial, Compliance, Europe|Tags: , , , , , |

European Medicines Agency published a new Guideline on the reporting of Serious Breaches, that will come into effect on January 31, 2022. Find out: ✔ how to report serious breach ✔ responsibilities of the different parties involved in the notification ✔ examples [...]

EUDAMED ACTOR MODULE FAQs – update

2023-03-29T15:48:06+00:00January 3rd, 2022|Categories: Compliance, Regulatory|Tags: , , , |

The European Commission has updated the Eudamed Actor Module FAQs. The document includes a revision of paragraph 4.6.4 relating to the publicly accessible contact details of Person Responsible for Regulatory Compliance (PRRC). Read more in the EC document. Contact Meditrial [...]

MDCG 2021-28 Substantial modification of clinical investigation under Medical Device Regulation

2023-03-29T15:49:01+00:00December 1st, 2021|Categories: Clinical Trial, Compliance, Europe, MDR, Regulatory|Tags: , , , , , , |

New guideline for Europe on trial changes has been published! MDCG 2021-28 - Substantial modification of clinical investigation under Medical Device Regulation. The sponsor of a clinical investigation is required to submit an application to the Member State in [...]

Go to Top